Furthermore, PD-1 can negatively regulate the activity of T cells via interacting with its ligands PD-L1 (B7-H1) and PD-L2 (B7-DC) expressing on immune cells and tumor cells at some steps of the immune response (12). The gene discussed is PDCD1; the disease is neoplasm.